TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
QGEN

Qiagen NV

Healthcare · Diagnostics & Research

44.80$ +6.4% vs. previous close Closing price · As of: Oct 2, 2026

Statements

Cash Flow

Qiagen NV (QGEN) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at 654 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Cash Flow QGEN
Line item 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
4.1 8.5 12 26 39 58 37 64 54 91 101 85 173 217 251 245 245 259 288 317 342 287 359 331 492 639 715 459 674 654
2.5 4.9 5.8 7.8 10 15 25 26 23 25 30 63 106 120 143 167 198 199 201 191 213 216 206 231 210 215 208 205 203 194
– – 0.6 – – – – – – – 326 8,982 9.8 9.7 14 20 25 38 42 28 28 34 40 66 41 38 50 47 44 50
– – – – 0.3 7.0 9.8 – – 5.6 0.5 7.5 – – – – – 24 16 4.4 19 93 22 144 -76 41 -95 – – –
-4.2 -4.7 -6.3 1.0 -12 -5.9 -14 -25 -20 -3.8 -5.1 -56 -18 -35 -16 -43 -84 5.7 -79 -81 10 -67 -95 -44 17 -130 -32 -187 135 -35
9.7 6.8 11 12 39 102 59 20 13 14 35 59 58 69 124 121 128 119 97 117 94 124 151 275 304 207 149 163 167 201
-38 -5.9 -12 -24 -45 -91 -65 -14 -51 -99 -165 -660 -211 -342 -216 -540 -301 -252 -408 -146 -179 -464 -211 -222 -443 -202 -727 -88 -249 -305
– – – – – – – – – – – – – – – – 400 0.0 786 – – 770 567 – 622 – 25 0.0 0.0 54
– – – – – – – – – – – – – – – – -36 -86 -127 -21 0.0 -61 -105 -74 -64 -100 -25 -18 -292 -307
– – – – – – – – – – – – – – – – – – 325 -253 -8.1 723 494 -640 -36 -41 -135 -437 -107 208
32 3.2 1.8 3.6 15 66 6.1 -1.9 96 3.0 303 494 13 629 -35 -311 227 -69 193 -259 -11 387 360 -639 -74 -150 -126 -434 -423 -179
-3.3 2.3 2.0 5.8 9.1 32 -12 54 97 -4.7 239 -83 -14 492 2.9 -607 173 -64 62 -103 149 219 501 -530 -31 283 -150 -63 -4.5 175
-5.6 1.7 1.1 14 -0.6 -44 -22 45 41 78 66 26 115 148 127 123 117 140 191 200 248 162 209 56 188 432 566 297 506 453

Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?